These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34675543)

  • 21. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retraction: CircBANP acts as a sponge of let-7a to promote gastric cancer progression
    Fisher L
    RSC Adv; 2021 Jan; 11(10):5700. PubMed ID: 35427047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.
    Zhang ZF; Wang YJ; Fan SH; Du SX; Li XD; Wu DM; Lu J; Zheng YL
    Oncotarget; 2022; 13():1003. PubMed ID: 36082358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-493 Inhibits Tongue Squamous Cell Carcinoma Oncogenicity via Directly Targeting HMGA2 [Retraction].
    Onco Targets Ther; 2021; 14():4737-4738. PubMed ID: 34526777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retraction: Upregulation of miR-26b alleviates morphine tolerance by inhibiting BDNF
    Fisher L
    RSC Adv; 2021 Jan; 11(7):4231. PubMed ID: 35427020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-769 is Downregulated in Colorectal Cancer and Inhibits Cancer Progression by Directly Targeting Cyclin-Dependent Kinase 1 [Retraction].
    Onco Targets Ther; 2021; 14():4851-4852. PubMed ID: 34602822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction].
    Onco Targets Ther; 2021; 14():4897-4898. PubMed ID: 34594110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction].
    Onco Targets Ther; 2021; 14():4991-4992. PubMed ID: 34675539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-605 Inhibits the Oncogenicity of Non-Small-Cell Lung Cancer by Directly Targeting Forkhead Box P1 [Retraction].
    Onco Targets Ther; 2021; 14():4933-4934. PubMed ID: 34611411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retraction: FNDC1 promotes the invasiveness of gastric cancer via Wnt/β-catenin signaling pathway and correlates with peritoneal metastasis and prognosis.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1490592. PubMed ID: 39355126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis via Wnt/β-Catenin Signaling Pathway [Retraction].
    Drug Des Devel Ther; 2023; 17():959-960. PubMed ID: 37013138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction].
    Onco Targets Ther; 2021; 14():4745-4746. PubMed ID: 34526781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy [Retraction].
    Onco Targets Ther; 2024; 17():129-130. PubMed ID: 38405177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
    Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retraction: TRIM22 functions as an oncogene in gliomas through regulating the Wnt/β-catenin signaling pathway.
    Fisher L
    RSC Adv; 2021 Jan; 11(9):5240. PubMed ID: 35427038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 38. MicroRNA-559 Plays an Inhibitory Role in the Malignant Progression of Glioblastoma Cells by Directly Targeting Metadherin [Retraction].
    Onco Targets Ther; 2021; 14():4899-4900. PubMed ID: 34594111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction].
    Onco Targets Ther; 2021; 14():4847-4848. PubMed ID: 34584423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction: Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma
    Jiang Z; Mao Z
    RSC Adv; 2024 May; 14(21):14514. PubMed ID: 38708109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.